Health services research clinical evaluation

Outcomes research is defined as studies that attempt to identify, measure, and evaluate the end results of health care services. Outcomes research may evaluate not only the clinical effects of health care services but also the economic and humanistic impact of these services. Proponents of outcomes research believe that we should measure not only the clinical and cost impacts of health care but also outcomes that take factors... 

Kapit, R. (1987, December 10). Review and evaluation of clinical data NDA 18-936 (Internal Document). Rockville, MD Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research. 

When thinking about pharmacy s involvement in HSR, it is helpful to use seven areas of HSR outlined in the lOM s 1995 report.These are 1) organization and financing of health services 2) access to health care 3) quality of care 4) clinical evaluation and outcomes research 5) informatics and clinical decision making ... 

Guidance for Industry For the Evaluation of Combination Vaccines for Preventable Diseases Production, Testing and Clinical Studies. U.S. Department of Health and Human Services, Food and Drug Administration Center for Biologies Evaluation and Research. April 1997. 

About the Author Dr. Doucette is a Professor in the Division of Clinical and Administrative Pharmacy at the College of Pharmacy of the University of Iowa. He received a B.S. in pharmacy, an M.S. in pharmacy administration, and a Ph.D. in social and administrative sciences in pharmacy from the University of Wisconsin. He has managed several community pharmacies. His teaching interests are in pharmacy management and marketing of health care, whereas his primary research interest is evaluating pharmacy services and collaboration between pharmacists and other health care professionals. Dr. Doucette has published his work in many pharmacy journals. 

Further evaluation of this tragic event has identified that vector-associated toxicity was not the sole cause for this patient s death. The FDA determined that human subjects in this investigation were not adequately protected and that there was substantial financial conflict of interest. Subsequently, the NIFl has discovered hundreds of unreported adverse events among volunteers enrolled in gene transfer experiments. These findings have catalyzed broad examination of the entire clinical research process, with the Secretary of Health and Human Services calling for broad reforms in informed consent, clinical monitoring, and conflict of interest. 

M3(R2) nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. U.S. department of health and human services food and drug administration center for drug evaluation and research (CDER) center for biologies evaluation and research (CBER) (2010)... 

---